Hereditární formy karcinomu prsu: genetická etiologie a současné možnosti prevence a chirurgické léčby
[Hereditary breast cancer: genetic etiology and current possibilities of prevention and surgical treatment]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
29790359
PII: 63616
- Klíčová slova
- BRCA1, BRCA2, TP53 surgical solutions., breast cancer, inheritance,
- MeSH
- genetická predispozice k nemoci * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mastektomie MeSH
- mutace MeSH
- nádory prsu * genetika prevence a kontrola chirurgie MeSH
- rizikové faktory MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Cancer is the second most common cause of death in our population just after cardiovascular diseases, since each third individual will become affected by it during their lifetime. Breast cancer is the most common malignancy in women. The lifetime cumulative risk of breast cancer in women under the age of 75 is around 8 % according to Czech statistics. In 70-75 % of all individuals sporadic breast carcinomas are found, with 5-10 % of all women suffer from the hereditary breast and ovarian cancer (HBOC) syndrome. Radical, bilateral, removal of the mammary gland is the most effective prevention of breast cancer in BRCA positive women. We present a summary of 37 BRCA positive Czech patients who underwent prophylactic bilateral mastectomy and whose mean age was 46.5 years. Surgical solution is currently the only effective therapeutic way to prevent breast cancer in BRCA positive women with high genetic risk. The cosmetic consequences of this radical surgery can be solved through many reconstruction tasks.